Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Briscoe
Rafiq Islam

Bioanalysis

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bioanalysis|November 15, 2011
Laboratory and software applications for clinical trials: the global laboratory environmentChad Briscoe
Bioanalysis|April 19, 2019
Perspectives on gender parity in bioanalysis: an interview with Chad BriscoeChad Briscoe
Bioanalysis|January 30, 2014
Bioanalytical challenges of biosimilarsRafiq Islam
Bioanalysis|November 7, 2024
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterionMarianne Scheel Fjording, Joanne Goodman, Chad Briscoe
Bioanalysis|July 19, 2013
Ask the experts: increasing and maintaining productivity in the bioanalytical laboratoryBrian D Beato, Chad Briscoe, Joe Rajarao, et al.
Bioanalysis|November 5, 2013
New setting for the Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Stacy Ho, Chad Briscoe, et al.
Bioanalysis|October 12, 2011
Conference report: 12th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Chad Briscoe, Lakshmi Amaravadi, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bioanalysis|November 15, 2011
Laboratory and software applications for clinical trials: the global laboratory environmentChad Briscoe
Bioanalysis|April 19, 2019
Perspectives on gender parity in bioanalysis: an interview with Chad BriscoeChad Briscoe
Bioanalysis|January 30, 2014
Bioanalytical challenges of biosimilarsRafiq Islam
Bioanalysis|November 7, 2024
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterionMarianne Scheel Fjording, Joanne Goodman, Chad Briscoe
Bioanalysis|July 19, 2013
Ask the experts: increasing and maintaining productivity in the bioanalytical laboratoryBrian D Beato, Chad Briscoe, Joe Rajarao, et al.
Bioanalysis|November 5, 2013
New setting for the Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Stacy Ho, Chad Briscoe, et al.
Bioanalysis|October 12, 2011
Conference report: 12th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Chad Briscoe, Lakshmi Amaravadi, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Pageof 3